Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.97
CHDX's Cash to Debt is ranked higher than
64% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. CHDX: 0.97 )
CHDX' s 10-Year Cash to Debt Range
Min: 0.5   Max: No Debt
Current: 0.97

Equity to Asset 0.67
CHDX's Equity to Asset is ranked higher than
87% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.37 vs. CHDX: 0.67 )
CHDX' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.76
Current: 0.67

0.3
0.76
F-Score: 4
Z-Score: 4.09
M-Score: -2.72
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Revenue Growth (%) -6.60
CHDX's Revenue Growth (%) is ranked lower than
62% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.60 vs. CHDX: -6.60 )
CHDX' s 10-Year Revenue Growth (%) Range
Min: -8.3   Max: 100.4
Current: -6.6

-8.3
100.4
EBITDA Growth (%) 57.40
CHDX's EBITDA Growth (%) is ranked higher than
97% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. CHDX: 57.40 )
CHDX' s 10-Year EBITDA Growth (%) Range
Min: -6.7   Max: 80.6
Current: 57.4

-6.7
80.6
» CHDX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2012

CHDX Guru Trades in Q2 2012

Jim Simons Sold Out
» More
Q1 2013

CHDX Guru Trades in Q1 2013

Jim Simons 14,311 sh (New)
» More
Q2 2013

CHDX Guru Trades in Q2 2013

Jim Simons Sold Out
» More
Q1 2014

CHDX Guru Trades in Q1 2014

Jim Simons 57,234 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with CHDX



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 2.60
CHDX's P/B is ranked higher than
66% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.36 vs. CHDX: 2.60 )
CHDX' s 10-Year P/B Range
Min: 0.55   Max: 8.09
Current: 2.6

0.55
8.09
P/S 2.13
CHDX's P/S is ranked higher than
55% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.68 vs. CHDX: 2.13 )
CHDX' s 10-Year P/S Range
Min: 0.27   Max: 2.87
Current: 2.13

0.27
2.87
EV-to-EBIT -312.76
CHDX's EV-to-EBIT is ranked lower than
55% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.16 vs. CHDX: -312.76 )
CHDX' s 10-Year EV-to-EBIT Range
Min: 1.4   Max: 506.7
Current: -312.76

1.4
506.7
Shiller P/E 117.80
CHDX's Shiller P/E is ranked higher than
68% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 81.32 vs. CHDX: 117.80 )
CHDX' s 10-Year Shiller P/E Range
Min: 24.41   Max: 757.5
Current: 117.8

24.41
757.5
Current Ratio 1.35
CHDX's Current Ratio is ranked higher than
54% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.53 vs. CHDX: 1.35 )
CHDX' s 10-Year Current Ratio Range
Min: 1.12   Max: 5.37
Current: 1.35

1.12
5.37
Quick Ratio 1.29
CHDX's Quick Ratio is ranked higher than
76% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. CHDX: 1.29 )
CHDX' s 10-Year Quick Ratio Range
Min: 0.73   Max: 5.29
Current: 1.29

0.73
5.29

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.60
CHDX's Price/Tangible Book is ranked higher than
79% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.98 vs. CHDX: 2.60 )
CHDX' s 10-Year Price/Tangible Book Range
Min: 0.19   Max: 5.63
Current: 2.6

0.19
5.63
Price/DCF (Projected) 6.00
CHDX's Price/DCF (Projected) is ranked higher than
68% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.63 vs. CHDX: 6.00 )
CHDX' s 10-Year Price/DCF (Projected) Range
Min: 1.24   Max: 59.03
Current: 6

1.24
59.03
Price/Median PS Value 1.80
CHDX's Price/Median PS Value is ranked lower than
54% of the 56 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.29 vs. CHDX: 1.80 )
CHDX' s 10-Year Price/Median PS Value Range
Min: 0.08   Max: 2.07
Current: 1.8

0.08
2.07
Earnings Yield (Greenblatt) 0.60
CHDX's Earnings Yield (Greenblatt) is ranked lower than
64% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. CHDX: 0.60 )
CHDX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 73.4
Current: 0.6

0.2
73.4
Forward Rate of Return (Yacktman) -6.79
CHDX's Forward Rate of Return (Yacktman) is ranked lower than
55% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.14 vs. CHDX: -6.79 )
CHDX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13.8   Max: 29.1
Current: -6.79

-13.8
29.1

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Chindex International, Inc., was founded in 1981 in Delaware. The Company operates in several healthcare markets in China, including Hong Kong. It generates its revenue from the provision of healthcare services and the sale of medical equipment, instrumentation and products. The Company operates in two business segments: the Medical Product Division and the Healthcare Services Division. It operates hospitals and clinics in Beijing, Shanghai, Tianjin and Guangzhou. These hospitals and clinics generally transact business in Chinese Renminbi. The Company historically also engaged in the distribution of western medical equipment to Chinese hospital purchasers through its former Medical Products division ("MPD"). Its Healthcare Services Business includes: United Family Beijing Market - Beijing United Family Hospital (BJU) and Clinics, United Family Shanghai Market—Shanghai United Family Hospital (SHU) and Clinics, United Family Tianjin Market - Tianjin United Family Hospital (TJU), United Family Guangzhou Market - Guangzhou United Family Clinic (GZC), United Family - The Investment Environment and New Market Development. There are no foreign investor-owned and operated hospital networks in China that compete with the United Family healthcare network in serving the expatriate, diplomatic and affluent local Chinese markets through a healthcare service delivery system.
» More Articles for CHDX

Headlines

Articles On GuruFocus.com
Chindex International Inc. Reports Operating Results (10-Q) Nov 08 2010 
Chindex International Inc. (CHDX) CEO and President Roberta Lipson sells 17,000 Shares Sep 15 2010 
Chindex International Inc. Reports Operating Results (10-Q) Aug 09 2010 
Chindex International Inc. Reports Operating Results (10-Q) Feb 08 2010 
Chindex International Inc. Reports Operating Results (10-Q) Nov 09 2009 
Chindex International Inc. Reports Operating Results (10-Q) Aug 10 2009 
Chindex International, Inc. Reports First Quarter Fiscal 2010 Financial Results Aug 10 2009 
Chindex International, Inc. Reports Third Quarter FY 2009 Financial Results Feb 09 2009 

More From Other Websites
Giant, RDA De-List As Deal-Making Slows Jul 22 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 30 2014
China healthcare reform to relax curbs on foreign investment in hospitals May 28 2014
China healthcare reform to relax curbs on foreign investment in hospitals May 28 2014
CHINDEX INTERNATIONAL INC Financials May 20 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 12 2014
Chindex International, Inc Earnings Call scheduled for 9:00 am ET today May 08 2014
Q1 2014 Chindex International, Inc Earnings Release - Before Market Open May 08 2014
Chindex International, Inc. Reports First Quarter 2014 Financial Results May 08 2014
Chindex Signs Previously-Disclosed Joint Venture Regarding Guangzhou United Family Hospital May 06 2014
Chindex International, Inc. to Report First Quarter 2014 Financial Results Apr 30 2014
China Biotech Week In Review: Chindex Taken Private By Fosun And TPG Apr 27 2014
The Alexander Firm P.C. Announces Investigation of Chindex International, Inc. and Its Board of... Apr 24 2014
The Alexander Firm P.C. Announces Investigation of Chindex International, Inc. and Its Board of... Apr 24 2014
Bidding War Breaks Out For Chindex Apr 24 2014
Fosun Pharma, TPG agree to buy Chindex in sweetened $461 mln deal Apr 21 2014
Fosun Pharma Boosts Offer for Chindex After Rival Bid Apr 21 2014
CHINDEX INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Material... Apr 21 2014
Chindex signs amended merger agreement with TPG and Fosun Pharma Apr 21 2014
Chindex Signs Amended Merger Agreement with TPG and Fosun Pharma -- Increases Consideration from... Apr 21 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide